A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
Clinical trial NCT05146869 · COMPLETED
Trial details
- NCT number
- NCT05146869
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2022-03-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.